In the study that found MCH a more useful than MCV in separating normal from α+ thalassemia homozygotes, the subjects' genotypes were known and α+ thalassemia heterozygotes were excluded from analysis [8], which we could not do. The gene discussed is PMCH; the disease is alpha thalassemia spectrum.